What is Harrow's EBITDA?

Harrow (HROW) reported EBITDA of -$21.63M in Q1 2026.

How has Harrow's EBITDA changed year-over-year?

Harrow's EBITDA decreased by 100.8% year-over-year, from -$10.77M to -$21.63M.

What is the long-term trend for Harrow's EBITDA?

Over 4 years (2021 to 2025), Harrow's EBITDA has grown at a 229.5% compound annual growth rate (CAGR), from -$275K to $32.43M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Harrow HROW EBITDA

EBITDA at other companies

Bausch + LombBLCO

$134M+483%

Ocular TherapeutixOCUL

-$92.06M-46.3%

Bausch Health CompaniesBHC

-$655M-213%

Tarsus Pharmaceuticals, Inc.TARS

-$5.69M+78.0%

AbbVieABBV

——

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$44.2M-7.6%

Gross profit$27.0M-16.3%

Operating income-$22.1M-96.6%

Net income-$27.6M-55.2%

EPS (diluted)-$0.74-48.0%

Balance sheet

See full

Cash & equivalents$94.6M+41.8%

Total debt$308.6M-32.9%

Total equity$28.7M-49.1%

Total assets$419.5M+15.2%

Cash flow

See full

Operating cash flow-$9.0M-146%

CapEx$194.0K+14.1%

Free cash flow-$9.2M-147%

Valuation

See full

Market cap$1.59B+38.4%

Enterprise value$1.81B+13.8%

P/S5.9×+0.5×

Profitability

See full

Gross margin74.1%-0.4pp

Operating margin7.3%+5.2pp

Net margin-19.8%+18.0pp

FCF margin5.7%+5.0pp

Returns & leverage

See full

Return on equity-50%+17.5pp

Debt / equity10.7×+2.6×

Current ratio2.5×+1.6×

Where this comes from

Calculated from Harrow’s reported figures.

−$22.1Mebit+

$455.0KDepreciation Depletion & Amortization

=-$21.63M

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Harrow's EBITDA?: Harrow (HROW) reported EBITDA of -$21.63M in Q1 2026.
How has Harrow's EBITDA changed year-over-year?: Harrow's EBITDA decreased by 100.8% year-over-year, from -$10.77M to -$21.63M.
What is the long-term trend for Harrow's EBITDA?: Over 4 years (2021 to 2025), Harrow's EBITDA has grown at a 229.5% compound annual growth rate (CAGR), from -$275K to $32.43M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.